Smithfield Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.72M | Buy |
77,766
+59,447
| +325% | +$3.47M | 0.21% | 69 |
|
|
2025
Q4 | $990K | Buy |
18,319
+2,841
| +18% | +$137K | 0.04% | 160 |
|
|
2025
Q3 | $699K | Sell |
15,478
-498
| -3% | -$23.3K | 0.03% | 193 |
|
|
2025
Q2 | $739K | Sell |
15,976
-400
| -2% | -$19.6K | 0.03% | 178 |
|
|
2025
Q1 | $999K | Sell |
16,376
-847
| -5% | -$49.4K | 0.05% | 147 |
|
|
2024
Q4 | $974K | Hold |
17,223
| – | – | 0.05% | 158 |
|
|
2024
Q3 | $890K | Buy |
17,223
+218
| +1% | +$10.2K | 0.04% | 164 |
|
|
2024
Q2 | $705K | Sell |
17,005
-2,993
| -15% | -$134K | 0.04% | 175 |
|
|
2024
Q1 | $1.09M | Sell |
19,998
-1,049
| -5% | -$53.4K | 0.06% | 140 |
|
|
2023
Q4 | $1.08M | Sell |
21,047
-1,271
| -6% | -$66.7K | 0.06% | 139 |
|
|
2023
Q3 | $1.29M | Sell |
22,318
-220
| -1% | -$13.5K | 0.08% | 119 |
|
|
2023
Q2 | $1.44M | Sell |
22,538
-207
| -0.9% | -$13.9K | 0.09% | 113 |
|
|
2023
Q1 | $1.57M | Sell |
22,745
-494
| -2% | -$34.8K | 0.1% | 102 |
|
|
2022
Q4 | $1.66M | Sell |
23,239
-68
| -0.3% | -$5.13K | 0.11% | 96 |
|
|
2022
Q3 | $1.65M | Buy |
23,307
+3,223
| +16% | +$234K | 0.12% | 90 |
|
|
2022
Q2 | $1.55M | Buy |
20,084
+1,236
| +7% | +$94.1K | 0.11% | 97 |
|
|
2022
Q1 | $1.36M | Buy |
18,848
+355
| +2% | +$23.8K | 0.09% | 111 |
|
|
2021
Q4 | $1.15M | Sell |
18,493
-1
| -0% | -$59 | 0.07% | 123 |
|
|
2021
Q3 | $1.09M | Sell |
18,494
-1,935
| -9% | -$127K | 0.07% | 119 |
|
|
2021
Q2 | $1.36M | Sell |
20,429
-440
| -2% | -$28.7K | 0.09% | 109 |
|
|
2021
Q1 | $1.32M | Sell |
20,869
-171
| -0.8% | -$10.6K | 0.09% | 112 |
|
|
2020
Q4 | $1.3M | Sell |
21,040
-751
| -3% | -$46.2K | 0.09% | 111 |
|
|
2020
Q3 | $1.31M | Sell |
21,791
-653
| -3% | -$39.3K | 0.11% | 109 |
|
|
2020
Q2 | $1.32M | Buy |
22,444
+2,251
| +11% | +$135K | 0.12% | 99 |
|
|
2020
Q1 | $1.13M | Buy |
20,193
+970
| +5% | +$59.3K | 0.12% | 94 |
|
|
2019
Q4 | $1.23M | Sell |
19,223
-426
| -2% | -$24.4K | 0.11% | 102 |
|
|
2019
Q3 | $996K | Buy |
19,649
+38
| +0.2% | +$1.79K | 0.1% | 108 |
|
|
2019
Q2 | $890K | Buy |
19,611
+100
| +0.5% | +$4.66K | 0.09% | 113 |
|
|
2019
Q1 | $930K | Buy |
19,511
+60
| +0.3% | +$2.99K | 0.1% | 111 |
|
|
2018
Q4 | $1.01M | Sell |
19,451
-2,930
| -13% | -$157K | 0.12% | 96 |
|
|
2018
Q3 | $1.39M | Sell |
22,381
-1,230
| -5% | -$73K | 0.15% | 87 |
|
|
2018
Q2 | $1.31M | Sell |
23,611
-145
| -0.6% | -$7.83K | 0.15% | 86 |
|
|
2018
Q1 | $1.5M | Sell |
23,756
-1,069
| -4% | -$68.8K | 0.18% | 78 |
|
|
2017
Q4 | $1.52M | Buy |
24,825
+4,585
| +23% | +$287K | 0.19% | 82 |
|
|
2017
Q3 | $1.29M | Hold |
20,240
| – | – | 0.18% | 81 |
|
|
2017
Q2 | $1.13M | Hold |
20,240
| – | – | 0.17% | 83 |
|
|
2017
Q1 | $1.1M | Sell |
20,240
-150
| -0.7% | -$8.23K | 0.17% | 79 |
|
|
2016
Q4 | $1.19M | Sell |
20,390
-2,045
| -9% | -$112K | 0.2% | 75 |
|
|
2016
Q3 | $1.21M | Sell |
22,435
-12,710
| -36% | -$816K | 0.22% | 63 |
|
|
2016
Q2 | $2.58M | Buy |
35,145
+1,000
| +3% | +$70.7K | 0.48% | 32 |
|
|
2016
Q1 | $2.18M | Buy |
34,145
+400
| +1% | +$25.2K | 0.42% | 40 |
|
|
2015
Q4 | $2.32M | Buy |
33,745
+1,276
| +4% | +$84.3K | 0.48% | 34 |
|
|
2015
Q3 | $1.92M | Hold |
32,469
| – | – | 0.41% | 38 |
|
|
2015
Q2 | $2.16M | Hold |
32,469
| – | – | 0.43% | 37 |
|
|
2015
Q1 | $2.09M | Sell |
32,469
-575
| -2% | -$36K | 0.41% | 39 |
|
|
2014
Q4 | $1.95M | Hold |
33,044
| – | – | 0.4% | 38 |
|
|
2014
Q3 | $1.69M | Hold |
33,044
| – | – | 0.34% | 51 |
|
|
2014
Q2 | $1.6M | Sell |
33,044
-2,204
| -6% | -$109K | 0.32% | 53 |
|
|
2014
Q1 | $1.83M | Sell |
35,248
-150
| -0.4% | -$7.98K | 0.37% | 49 |
|
|
2013
Q4 | $1.88M | Buy |
35,398
+1,530
| +5% | +$77.9K | 0.38% | 45 |
|
|
2013
Q3 | $1.57M | Sell |
33,868
-1,300
| -4% | -$57.1K | 0.36% | 52 |
|
|
2013
Q2 | $1.57M | Buy |
+35,168
| New | +$1.53M | 0.38% | 51 |
|
Other funds holding BMY
VCM
VPM
Smithfield Trust's BMY Position: Q1 2026 in Review
Smithfield Trust increased its Bristol-Myers Squibb (BMY) stake by 325% in Q1 2026, buying an estimated $3.47M and bringing the position to 77,766 shares worth $4.72M. The position accounts for 0.21% of the portfolio, ranked #69.
Smithfield Trust first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Smithfield Trust held 77,766 shares of Bristol-Myers Squibb worth $4.72M as of Q1 2026.
- Smithfield Trust bought 59,447 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.47M.
- Bristol-Myers Squibb made up 0.21% of Smithfield Trust's portfolio in Q1 2026, its #69 holding.
- Smithfield Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.